Products Categories
| CAS No.: | 140703-51-1 |
|---|---|
| Name: | Hexarelin |
| Molecular Structure: | |
|
|
|
| Formula: | C47H58N12O6 |
| Molecular Weight: | 887.04 |
| Synonyms: | L-Histidyl-2-methyl-D-tryptophyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide;Examorelin;L-Lysinamide,L-histidyl-2-methyl-D-tryptophyl-L-alanyl-L-tryptophyl-D-phenylalanyl-; |
| EINECS: | 1312995-182-4 |
| Density: | 1.322 g/cm3 |
| Boiling Point: | 1403.6 °C at 760 mmHg |
| Flash Point: | 802.7 °C |
| Appearance: | White Powder |
| PSA: | 300.89000 |
| LogP: | 5.39220 |
- 144851-82-1METHYL2-AMINO-3-FLUOROBENZOATE
- 483366-12-7(2S,4R)-1-Boc-2-cyano-4-hydroxypyrrolidine
- 173606-50-3BOC-10-AMINODECANOIC ACID
- 361456-36-2METHYL (R)-(+)-ISOCYANATO-3-PHENYLPROPI&
- 5156-58-1N-(1-Benzyl-4-pipperidinyl)-N-phenylpropanamide HCl
- 81281-59-67-Benzylideneaminotheophylline
- 50288-62-5threo-Phenyl-2-piperidyl acetamide
- 82993-81-5D-threo-Ritalinic acid hydrochloride
- 47087-37-6Z-D-Glu-OMe
- 73441-42-6METHYL-5-CHLORO-2,2-DIMETHYLVALERATE
- 14075-53-7Potassium tetrafluoroborate
- 140-79-4N,N'-DINITROSOPIPERAZINE
- 1408002-81-2(S)-1-Boc-pyrrolidine-3-carboxylic acid hydrazide
- 140-93-2Proxan sodium
- 14104-20-2Silver tetrafluoroborate
- 141120-17-42-aminoindan-2-phosphonic acid
- 141250-43-32,7-Naphthalenedisulfonic acid, 4-amino-3,6-bis5-4-chloro-6-(2-methyl-4-sulfophenyl)amino-1,3,5-triazin-2-ylamino-2-sulfophenylazo-5-hydroxy-, sodium salt
- 14128-73-5BIS(2-METHYL-8-HYDROXYQUINOLINATO)ZINC
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
What can I do for you?
Get Best Price
Specification
1. Introduction of Hexarelin
Hexarelin is one kind of white powder. The IUPAC name of Hexarelin is 6-amino-2-[[2-[[2-[2-[[2-[[2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-(2-methyl-1H-indol-3-yl)propanoyl]amino]propanoylamino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanamide. Hexarelin belongs to belongs to Peptide;Glucagon receptor and related;Peptides. In addition, Hexarelin is a synthetic growth hormone releasing peptide; structurally similar to GHRP-6, with the substitution of D-Trp with its 2-methyl derivative; more potent & stable and less toxic than GHRP-6. Besides, it can soluble in water or 1% acetic acid.
2. Properties of Hexarelin
Physical properties about Hexarelin are:
(1)ACD/LogP: 1.97; (2)# of Rule of 5 Violations: 3; (3)ACD/BCF (pH 5.5): 1; (4)ACD/BCF (pH 7.4): 1; (5)ACD/KOC (pH 5.5): 1; (6)ACD/KOC (pH 7.4): 1; (7)#H bond acceptors: 18; (8)#H bond donors: 14; (9)#Freely Rotating Bonds: 25; (10)Polar Surface Area: 156.02 Å2; (11)Index of Refraction: 1.66; (12)Molar Refractivity: 247.69 cm3; (13)Molar Volume: 670.7 cm3; (14)Polarizability: 98.19×10-24cm3; (15)Surface Tension: 66.5 dyne/cm; (16)Density: 1.322 g/cm3; (17)Flash Point: 802.7 °C; (18)Enthalpy of Vaporization: 214.68 kJ/mol; (19)Boiling Point: 1403.6 °C at 760 mmHg; (20)Vapour Pressure: 0 mmHg at 25°C.
3. Structure Descriptors of Hexarelin
You can still convert the following datas into molecular structure:
(1)SMILES: O=C(N)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](N)Cc1cncn1)Cc3c2ccccc2nc3C)C)Cc5c4ccccc4nc5)Cc6ccccc6)CCCCN
(2)InChI: InChI=1/C47H58N12O6/c1-27-34(33-15-7-9-17-37(33)54-27)23-41(58-44(62)35(49)22-31-25-51-26-53-31)45(63)55-28(2)43(61)57-40(21-30-24-52-36-16-8-6-14-32(30)36)47(65)59-39(20-29-12-4-3-5-13-29)46(64)56-38(42(50)60)18-10-11-19-48/h3-9,12-17,24-26,28,35,38-41,52,54H,10-11,18-23,48-49H2,1-2H3,(H2,50,60)(H,51,53)(H,55,63)(H,56,64)(H,57,61)(H,58,62)(H,59,65)/t28-,35-,38-,39+,40-,41+/m0/s1
(3)InChIKey: RVWNMGKSNGWLOL-GIIHNPQRBK
4. Uses of Hexarelin
Hexarelin is used for curing the lack of somatotropic hormone. Hexarelin is a six-amino acid peptide. Studies have shown that hexarelin is actually more effective and longer lasting than growth hormone releasing hormone (GHRH). It is also known that GHRP-6 has a synergistic effect with GHRH, causing a far greater release than either of these substances alone. By combining GHRP-6 with Hexarelin, a more potent GH releasing peptide combination is created than ever heard of. The potential clinical usefulness of these GH releasing hexapeptides is also reinforced by observations that long-term administration produces elevations in circulating IGF-1 concentrations. Long term treatment with GHRP-6 similarly has been shown to elevate serum IGF-1 as well as IGF-binding protein-3 concentrations and promote linear growth.